论文部分内容阅读
Bell′s麻痹的病因学至今不明,其治疗也存有争议。1980年Stennert提出一种联合治疗方案,即静脉输入大剂量类固醇和低分子葡聚糖,同时口服乙酮可可碱(Pentoxiphyline)(SD疗法),其结果与口服小剂量类固醇和扩血管药、ATP及维生素的结果(简称口服疗法一译者)对比,疗效满意。本文作者在Stennert治疗方案的基础上加以改进后,自1982年1月至1988年2月共治疗231名Bell′s麻痹患者,临床随访直至完全康复,不完全恢复者至少随访6个月。根据麻痹程度将病人分为完全性麻痹(面神经运动得分<15分)与不完全性麻痹(面神经运动得分>20分)二组,172例用SD疗法,其中111例为完全性麻痹,
The etiology of Bell’s paralysis remains unknown and its treatment is controversial. In 1980, Stennert proposed a combination therapy consisting of intravenous administration of high-dose steroids and low-molecular-weight dextran and concurrent oral administration of Pentoxiphyline (SD therapy). This result was associated with oral administration of small doses of steroids and vasodilators, ATP And vitamin results (referred to as a translator therapy) comparison, the effect is satisfactory. Based on the Stennert regimen, the authors treated 231 patients with Bell’s paralysis from January 1982 to February 1988 with clinical follow-up until complete recovery, with incomplete recovery for at least 6 months. According to degree of paralysis, patients were divided into two groups: complete paralysis (facial nerve movement score <15 points) and incomplete paralysis (facial nerve movement score> 20 points), 172 cases were treated with SD, of which 111 cases were complete paralysis,